Exhibit 4.3
AMENDMENT NO. 2 TO AGREEMENT IN PRINCIPLE
THIS AMENDMENT NO. 2 TO AGREEMENT IN PRINCIPLE, dated as of January 27,
1998 (this "Amendment"), by and between NAPRO BIOTHERAPEUTICS, INC., a Delaware
corporation (the "Company"), and the undersigned holder (the "Holder") of one of
the Company's Senior Convertible Notes due June 4, 2000 (the "Note").
The Company and the Holder agree as follows:
1. The Company and the Holder have executed and delivered, one to the
other, an Agreement in Principle, dated as of January 6, 1998, as amended by
Amendment No. 1 thereto, dated January 16, 1998 (as so amended, the
"'Agreement").
2. The Agreement is hereby amended to change the per share dollar amount in
Section 2 of the Agreement from $3.75 to $3.00.
3. Except as modified hereby, the Agreement remains in full force and
effect in accordance with its terms.
4. This Amendment shall be governed by and construed in accordance with
the laws of the State of New York applicable to contracts to be made and
performed entirely in the State of New York.
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
duly executed by their officers or other representatives as of the date first
set forth above.
NAPRO BIOTHERAPEUTICS, INC.
By: /s/ Xxxxxx X. Link, Jr.
Name: Xxxxxx X. Link, Jr.
Title: Vice President
OMICRON PARTNERS, L.P.
By: /s/
Name:
Title:
#370535
